Ranbaxy Gains 1% Following Settlement Of Litigation
Advertisement
Advertisement
Advertisement
Shares of As per the settlement agreement, Ranbaxy will pay $39.75 million to Texas by August 2015.
The claims are regarding how Ranbaxy reported pricing data to Texas Medicaid for some of its drugs. Ranbaxy says it fully complied with all the laws, but it settled the matter to “avoid any further distraction and uncertainty of continued litigation with the State of Texas.”
Advertisement
- Fresh photographs of Milky Way’s black hole Sgr A* reveal strong, twisted magnetic field similar to M87*
- 8 Lesser-known places to explore in Himachal Pradesh
- Markets end FY24 on buoyant note amid positive global cues
- SRM Contractors IPO allotment – How to check allotment, GMP, listing date and more
- Rupee falls 6 paise to settle at 83.39 against US dollar